医药行业周报：勃林格殷格翰Zongertinib拟纳入优先审评
太平洋·2024-12-30 01:01
勃林格殷格翰 Zongertinib 拟纳入优先审评 | --- | --- | --- | --- | |--------------------------------------------------------|--------------------------|-------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...